RESULTS: Serum vitamin D levels in poorly controlled T2DM subjects (9.4 (4.9-34) ng/ml) were significantly lower than that of the relatively well regulated T2DM patients (13.5 (3.4-36) 
INTRODUCTION
Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder, which is caused by deterioration in secretion or action of insulin. Prevalence of T2DM has been reached nearly pandemic levels worldwide, in parallel to the increase in obesity.
The role of vitamin D in many bodily functions has been researched after discovery of vitamin D receptors in pancreas and immune cells 1 . It has been reported that subjects with insufficient vitamin D were prone to develop type 2 diabetes mellitus 2 . Moreover, impaired glucose tolerance has been shown to be meliorated in vitamin D deficient subjects after vitamin D replacement 3 . Few studies analyzed the possible association between vitamin D serum levels and glycated hemoglobin (HbA1c) in patients with T2DM. Several ORIGINAL ARTICLE dr.ediperkus@gmail.com mehmetzahidkocak@hotmail.com doktortuuba@gmail.com burcinatak@hotmail.com emirsvl@hotmail.com of these reports found an association and others did not. Indeed, vitamin D deficiency could be associated with development of T2DM or diabetic control level. Therefore, we planned a present retrospective study.
OBJECTIVE
In the present retrospective analysis, we aimed to study the possible association between serum vitamin D concentration and HbA1c level in patients with type 2 diabetes mellitus.
METHODS
Patients' admissions to outpatient clinics of our institution who have T2DM retrospectively investigated from patient files and computerized database between November 2016 and June 2017. Subjects grouped either into regulated T2DM or into non-regulated T2DM groups, according to HbA1c levels. An HbA1c level of <8% was considered as relatively controlled and others were considered as uncontrolled T2DM. Patients with active inflammation, infection, malignancy or chronic kidney disease were excluded from the study. Patients receiving vitamin D supplements were also excluded. Age, gender and other general characteristics, such as height, weight, duration of T2DM and waist circumference were recorded. A body mass index (BMI) was calculated by dividing of the weight in kilograms to the square of height in meters.
Vitamin D levels, serum urea, creatinine, fasting plasma glucose, total, HDL and LDL cholesterol, triglyceride and albumin were obtained from the same database and recorded. HbA1c levels were also obtained and recorded from patient file system. Vitamin D levels were detected by measuring serum 25-hydroxyvitamin D.
Data were analyzed by SPSS software. (SPSS 15.0; IBM Inc., Chicago, IL, USA). Results expressed as mean ± SD or median (minimum -maximum). Variables are conducted with independent samples t test or MannWhitney U test. Chi square test used in comparison of categorical variables between study groups. A p value of < 0.05 is considered as statistically significant. Pearson's correlation analysis test used to reveal possible correlation between vitamin D and HbA1c levels.
RESULTS
The study population was consisted of 89 diabetic subjects; 47 in poorly controlled and 42 in relatively Twenty of 42 subjects in relatively well-controlled T2DM group and 30 of 47 in poorly controlled T2DM group were women. Gender was not statistically different between study groups (p=0.12).
Fasting plasma glucose levels of poorly controlled and well-controlled diabetic subjects were 209 (89-422) mg/dl and 126 (78-294) mg/dl, respectively. The difference was statistically significant, as expected (p<0.001). Similarly, HbA1c of poorly controlled diabetics (9.7 [8-16.6] %) was significantly higher than that of the relatively well-controlled diabetic subjects (6.9 [5.4-7.7 ] %), again expectedly (p<0.001). General characteristics and laboratory data of study population were expressed in table 1.
Body mass index (p=0.22), waist circumference (p=0.33), blood urea (p=0.62) and creatinine (p=0.26), total (p=0.53) and HDL (p=0.53) cholesterol, plasma sodium (p=0.24) and potassium (p=0.12) concentrations, and serum albumin levels (p=0.17) were not significantly different between study groups.
Serum LDL (p=0.04) and triglyceride (p=0.03) were significantly higher in poorly controlled compared to well-controlled diabetic subjects. Duration of T2DM was significantly longer in poorly regulated compared to relatively well-regulated T2DM group (p=0.02).
Vitamin D serum levels in poorly and well-regulated T2DM groups were 9.4 (4.9-34) ng/ml and 13.5 (3.4-36) ng/ml, respectively. The difference between study groups was statistically significant (p=0.03).
Pearson correlation analysis revealed that serum vitamin D was strongly and inversely correlated with HbA1c levels (r= -0.295, p=0.005). Figure 1 shows the correlation between vitamin D and HbA1c (figure 1).
DISCUSSION
The main finding of the present study is that vitamin D levels were negatively and strongly correlated with HbA1c levels in patients with T2DM. HbA1c reflects blood glucose of the last 3 months and is considered as a marker of diabetic regulation. This negative correlation could be the consequence of vitamin D being a metabolic biomarker besides its action in bone and calcium metabolism.
Hypovitaminosis of vitamin D have negative effects on both calcium and bone metabolism and diabetes mellitus 4 . Besides its crucial role in calcium and bone metabolism, recent discoveries showed . In another study, researchers found that vitamin D was more effective than metformin in ameliorating insulin resistance in subjects with metabolic syndrome 2 . Similar results have been reported in literature. Subjects with T2DM had reduced serum vitamin levels compared to healthy population in a study by Scragg et al. 
11
. Despite oral vitamin D increased the insulin secretion following oral glucose intake in healthy subjects, its effect was neutral in patients with T2DM . However, a recent randomized controlled trial revealed that vitamin D supplementation was failed to alter HbA1c levels in patients with type 2 diabetes mellitus
16,17
. Negative correlation between vitamin D and HbA1c levels in this study may support other studies that found association between T2DM and vitamin D status.
Lower vitamin D levels in patients with poor diabetic control compared to better-controlled subjects should be well examined. There are studies that reported vitamin D insufficiency was not the cause but the result of diabetes mellitus. Insulin stimulates production of vitamin D, thus, insulin deficiency or inefficacy as seen in diabetes mellitus may result in a decrease in vitamin D levels
5
. Retrospective design and small study population are two main limitations of the present report. Nevertheless, the striking negative correlation between serum vitamin D and HbA1c make its results very important.
CONCLUSION
Either the cause or result, it is clear that lower vitamin D is strongly associated with worse diabetic regulation in T2DM subjects. Randomized controlled larger studies that research the relation between diabetic regulation and vitamin D status are needed to claim whether it could be a therapeutic target in future in diabetic subjects. (13,5 (3,4-36) 
Acknowledgement

